FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jorge Romaguera

Research Profile

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Jason R Westin; Vince D Cataldo; Wenli Dong; Michelle A Fanale; Luis E Fayad; Nathan Fowler; Camillo Jimenez; Larry W Kwak; Peter McLaughlin; William A Murphy; Sattva S Neelapu; Barbara Pro; Jorge Romaguera; Felipe Samaniego; Perpetua Sanjorjo; Jatin Shah; Michael A Thompson; Bela Toth; Fredrick B Hagemeister
Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial.
Anas Younes; Amanda Copeland; Silvana de Castro Faria; Kantharaj Ethirajulu; Michelle A Fanale; Fredrick Hagemeister; Stefan Hart; Ramesh Jayaraman; Larry W Kwak; Peter McLaughlin; Sattva S Neelapu; Jorge Romaguera; Jatin Shah; Jeanette Wood; Joy Zhu
Phase I study of a novel oral Janus kinase 2 inhibitor, SB1518, in patients with relapsed lymphoma: evidence of clinical and biologic activity in multiple lymphoma subtypes.
Liang Zhang; Larry W Kwak; Haiyan Li; Jianfei Qian; Jorge Romaguera; Michael Wang; Jing Yang; Qing Yi
Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jorge Romaguera (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jason R Westin; Vince D Cataldo; Wenli Dong; Michelle A Fanale; Luis E Fayad; Nathan Fowler; Camillo Jimenez; Larry W Kwak; Peter McLaughlin; William A Murphy; Sattva S Neelapu; Barbara Pro; Jorge Romaguera; Felipe Samaniego; Perpetua Sanjorjo; Jatin Shah; Michael A Thompson; Bela Toth; Fredrick B Hagemeister
Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial.
Clinical lymphoma, myeloma & leukemia 2013;13(2):99-105.
2012: Anas Younes; Amanda Copeland; Silvana de Castro Faria; Kantharaj Ethirajulu; Michelle A Fanale; Fredrick Hagemeister; Stefan Hart; Ramesh Jayaraman; Larry W Kwak; Peter McLaughlin; Sattva S Neelapu; Jorge Romaguera; Jatin Shah; Jeanette Wood; Joy Zhu
Phase I study of a novel oral Janus kinase 2 inhibitor, SB1518, in patients with relapsed lymphoma: evidence of clinical and biologic activity in multiple lymphoma subtypes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(33):4161-7.
2012: Liang Zhang; Larry W Kwak; Haiyan Li; Jianfei Qian; Jorge Romaguera; Michael Wang; Jing Yang; Qing Yi
Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells.
Blood 2012;120(18):3783-92.
2012: Jinsheng Weng; Fuliang Chu; David A Delgado; Michelle A Fanale; Luis Fayad; Larry W Kwak; Amber Luong; Hyun Jun Park; Seema Rawal; Jorge Romaguera; Rakesh Sharma; Sattva S Neelapu
TCL1: a shared tumor-associated antigen for immunotherapy against B-cell lymphomas.
Blood 2012;120(8):1613-23.
2012: Anas Younes; Amanda Copeland; Michelle A Fanale; Silvana de Castro Farial; Luis Fayad; Fredrick Hagemeister; Stella Kim; Larry W Kwak; John M Lambert; Rodica Morariu-Zamfir; Sattva S Neelapu; Sandrine Payrard; Jorge Romaguera; Leo I Gordon
Phase I multidose-escalation study of the anti-CD19 maytansinoid immunoconjugate SAR3419 administered by intravenous infusion every 3 weeks to patients with relapsed/refractory B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(22):2776-82.
2012: Michael Wang; Anas Younes; Ken H Young; Jerome Zeldis; Liang Zhang; Felipe Samaniego; Luhong Sun; Nicolaus Wagner-Bartak; Maria Badillo; Maria Bejarano; Neda Bell; Catriona Byrne; Fernando Cabanillas; Richard Champlin; Wendy Chen; Yiming Chen; Michelle A Fanale; Luis Fayad; Lei Feng; Nathan Fowler; Fredrick Hagemeister; Kimberly Hartig; Larry W Kwak; Peter McLaughlin; Sattva S Neelapu; Kate J Newberry; Jorge Romaguera
Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial.
The lancet oncology 2012;13(7):716-23.
2012: S Vadhan-Raj; M Wang; Anas Younes; X Zhou; Felipe Samaniego; N J Sarlis; J Shah; C E Bueso-Ramos; J E Cortes; Michelle A Fanale; Luis Fayad; N Fowler; Fredrick B Hagemeister; Larry W Kwak; P W McLaughlin; Robert Z Orlowski; Barbara Pro; A Rodriguez; Jorge Romaguera
A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(6):1640-5.
2012: Yasuhiro Oki; Jorge Romaguera; Amanda Copeland; Michelle Fanale; Silvana de Castro Faria; Luis Fayad; Percy Ivy; L Jeffrey Medeiros; Anas Younes
Clinical experience with the heat shock protein-90 inhibitor, tanespimycin, in patients with relapsed lymphoma.
Leukemia & lymphoma 2012;53(5):990-2.
2012: Yasuhiro Oki; Jorge Romaguera; Amanda Copeland; Michelle Fanale; Luis E Fayad; Fredrick Hagemeister; Anas Younes
Experience with obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist in patients with relapsed or refractory classical Hodgkin lymphoma.
Blood 2012;119(9):2171-2.
2011: Richard J Jones; Sattva S Neelapu; Veerabhadran Baladandayuthapani; Luis Fayad; Jorge Romaguera; Rakesh Sharma; Michael Wang; Dajun Yang; Robert Z Orlowski
HDM-2 inhibition suppresses expression of ribonucleotide reductase subunit M2, and synergistically enhances gemcitabine-induced cytotoxicity in mantle cell lymphoma.
Blood 2011;118(15):4140-9.
2011: Deborah A Thomas; Susan O'Brien; Stefan Faderl; John T Manning; Jorge Romaguera; Luis Fayad; Fredrick Hagemeister; Jeffrey Medeiros; Jorge Cortes; Hagop Kantarjian
Burkitt lymphoma and atypical Burkitt or Burkitt-like lymphoma: should these be treated as different diseases?
Current hematologic malignancy reports 2011;6(1):58-66.
2010: Jorge Romaguera; Luis Fayad; Peter McLaughlin; Barbara Pro; Alma Rodriguez; Michael Wang; Pamela Weaver; Kimberly Hartig; Larry W Kwak; Tatyana Feldman; Judy Smith; Peggy Ford; Stuart Goldberg; Andrew Pecora; Andre Goy
Phase I trial of bortezomib in combination with rituximab-HyperCVAD alternating with rituximab, methotrexate and cytarabine for untreated aggressive mantle cell lymphoma.
British journal of haematology 2010;151(1):47-53.
2010: Jorge Romaguera; Luis Fayad; Lei Feng; Kimberly Hartig; Pamela Weaver; Maria Alma Rodriguez; Fredrick B Hagemeister; Barbara Pro; Peter McLaughlin; Anas Younes; Felipe Samaniego; Andre Goy; Fernando Cabanillas; Andrew Lamb; Larry Kwak; Michael Wang
Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma.
British journal of haematology 2010;150(2):200-8.
2010: Sanjay Gupta; Mark Sultenfuss; Jorge Romaguera; Joe Ensor; Savitri Krishnamurthy; Michael J Wallace; Kamran Ahrar; David C Madoff; Ravi Murthy; Marshall E Hicks
CT-guided percutaneous lung biopsies in patients with haematologic malignancies and undiagnosed pulmonary lesions.
Hematological oncology 2010;28(2):75-81.
2009: Michael Wang; Yasuhiro Oki; Barbara Pro; Jorge Romaguera; Maria Alma Rodriguez; Felipe Samaniego; Peter McLaughlin; Fredrick Hagemeister; Sattva S Neelapu; Amanda Copeland; Barry Samuels; Evelyne M Loyer; Yuan Ji; Anas Younes
Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(31):5213-8.
2009: Kedar V Inamdar; Jorge Romaguera; Elias Drakos; Ronald J Knoblock; Mar Garcia; Vasiliki Leventaki; L Jeffrey Medeiros; George Z Rassidakis
Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine.
Cancer 2009;115(20):4727-36.
2009: Bita Esmaeli; Peter McLaughlin; Barbara Pro; Felipe Samaniego; Isis Gayed; Fredrick Hagemeister; Jorge Romaguera; Fernando Cabanillas; Sattva S Neelapu; R Banay; Luis Fayad; M Wayne Saville; Larry W Kwak
Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(4):709-14.
2009: Mar Garcia; Jorge Romaguera; Kedar V Inamdar; George Z Rassidakis; L Jeffrey Medeiros
Proliferation predicts failure-free survival in mantle cell lymphoma patients treated with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with rituximab plus high-dose methotrexate and cytarabine.
Cancer 2009;115(5):1041-8.
2008: Michael Wang; Luis Fayad; Fernando Cabanillas; Fredrick Hagemeister; Peter McLaughlin; Maria A Rodriguez; Larry W Kwak; Yuhong Zhou; Andrew Lamb; Jorge Romaguera
Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.
Cancer 2008;113(10):2734-41.
2008: Barbara Pro; Brian Leber; Mitchell Smith; Luis Fayad; Jorge Romaguera; Fredrick Hagemeister; Alma Rodriguez; Peter McLaughlin; Felipe Samaniego; James Zwiebel; Adriana Lopez; Larry Kwak; Anas Younes
Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma.
British journal of haematology 2008;143(3):355-60.
2008: Jatin J Shah; Luis Fayad; Jorge Romaguera
Mantle Cell International Prognostic Index (MIPI) not prognostic after R-hyper-CVAD.
Blood 2008;112(6):2583; author reply 2583-4.
2008: Michael Wang; Liang Zhang; Xiaohong Han; Jing Yang; Jianfei Qian; Sungyoul Hong; Pei Lin; Yuankai Shi; Jorge Romaguera; Larry W Kwak; Qing Yi
A severe combined immunodeficient-hu in vivo mouse model of human primary mantle cell lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(7):2154-60.
2008: M J Overman; L Feng; Barbara Pro; Peter McLaughlin; Mark Hess; Felipe Samaniego; Anas Younes; Jorge Romaguera; Fredrick B Hagemeister; Larry W Kwak; Fernando Cabanillas; Maria A Rodriguez; Luis Fayad
The addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(3):553-9.
2008: Yasuhiro Oki; Barbara Pro; Luis Fayad; Jorge Romaguera; Felipe Samaniego; Fredrick Hagemeister; Sattva S Neelapu; Peter McLaughlin; Andre Goy; Anas Younes
Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma.
Cancer 2008;112(4):831-6.
2008: Paolo Anderlini; Rima M Saliba; Sandra Acholonu; Sergio Giralt; Borje Andersson; Naoto T Ueno; Chitra Hosing; Issa F Khouri; Daniel Couriel; Marcos De Lima; Muzaffar H Qazilbash; Barbara Pro; Jorge Romaguera; Luis Fayad; Fredrick Hagemeister; Anas Younes; Mark F Munsell; Richard E Champlin
Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience.
Haematologica 2008;93(2):257-64.
2007: Luis Fayad; Deborah Thomas; Jorge Romaguera
Update of the M. D. Anderson Cancer Center experience with hyper-CVAD and rituximab for the treatment of mantle cell and Burkitt-type lymphomas.
Clinical lymphoma & myeloma 2007;8 Suppl 2():S57-62.
2007: Andres O Soriano; Michael A Thompson; Joan H Admirand; Luis Fayad; Alma M Rodriguez; Jorge Romaguera; Fredrick B Hagemeister; Barbara Pro
Follicular dendritic cell sarcoma: a report of 14 cases and a review of the literature.
American journal of hematology 2007;82(8):725-8.
2007: Michael Wang; Liang Zhang; Xiaohong Han; Jing Yang; Jianfei Qian; Sungyoul Hong; Felipe Samaniego; Jorge Romaguera; Qing Yi
Atiprimod inhibits the growth of mantle cell lymphoma in vitro and in vivo and induces apoptosis via activating the mitochondrial pathways.
Blood 2007;109(12):5455-62.
2007: Nam H Dang; Barbara Pro; Fredrick B Hagemeister; Felipe Samaniego; Dan Jones; Barry Samuels; Maria A Rodriguez; Andre Goy; Jorge Romaguera; Peter McLaughlin; Ann T Tong; Francesco Turturro; Pamela L Walker; Luis Fayad
Phase II trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphoma.
British journal of haematology 2007;136(3):439-47.
2006: Amar Safdar; Maria A Rodriguez; Luis Fayad; Gilhen H Rodriguez; Barbara Pro; Michael Wang; Jorge Romaguera; Andre Goy; Fredrick B Hagemeister; Peter McLaughlin; Gerald P Bodey; Larry W Kwak; Issam I Raad; Robert B Couch
Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma.
The Journal of infectious diseases 2006;194(10):1394-7.
2006: Anas Younes; Luis Fayad; Jorge Romaguera; Barbara Pro; Andre Goy; Michael Wang
Safety and efficacy of once-per-cycle pegfilgrastim in support of ABVD chemotherapy in patients with Hodgkin lymphoma.
European journal of cancer (Oxford, England : 1990) 2006;42(17):2976-81.
2006: Barbara Pro; Fredrick B Hagemeister; Peter McLaughlin; Jorge Romaguera; Maria A Rodriguez; Fernando Cabanillas; Lili Paz Tiongson; Anas Younes
Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 2006;47(9):1818-21.
2006: Michael Wang; Yuhong Zhou; Liang Zhang; C Ann Nguyen; Jorge Romaguera
Use of bortezomib in B-cell non-Hodgkin's lymphoma.
Expert review of anticancer therapy 2006;6(7):983-91.
2006: Qi Liu; Luis Fayad; Fernando Cabanillas; Fredrick B Hagemeister; Gregory D Ayers; Mark Hess; Jorge Romaguera; Maria A Rodriguez; Apostolia-Maria Tsimberidou; Srdan Verstovsek; Anas Younes; Barbara Pro; Ming-Sheng Lee; Ana Ayala; Peter McLaughlin
Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(10):1582-9.
2006: Barbara Pro; Luis Fayad; Peter McLaughlin; Jorge Romaguera; Fredrick B Hagemeister; Maria A Rodriguez; Andre Goy; Evelyne M Loyer; Anas Younes
Pegfilgrastim administered in a single fixed dose is effective in inducing neutrophil count recovery after paclitaxel and topotecan chemotherapy in patients with relapsed aggressive non-Hodgkin's lymphoma.
Leukemia & lymphoma 2006;47(3):481-5.
2005: Jorge Romaguera; Luis Fayad; Maria A Rodriguez; Kristine Broglio; Fredrick B Hagemeister; Barbara Pro; Peter McLaughlin; Anas Younes; Felipe Samaniego; Andre Goy; Andreas H Sarris; Nam H Dang; Michael Wang; Virginia Beasley; L Jeffrey Medeiros; Ruth Katz; Harish K Gagneja; Barry Samuels; Terry L Smith; Fernando Cabanillas
High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7013-23.
2005: Chul Ha; Fernando Cabanillas; Ming S Lee; Susan L Tucker; Peter McLaughlin; Maria A Rodriguez; Anas Younes; Jorge Romaguera; Ofelia M Mesina; James D Cox
A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma.
International journal of radiation oncology, biology, physics 2005;63(1):188-93.
2005: Apostolia-Maria Tsimberidou; Anas Younes; Jorge Romaguera; Fredrick B Hagemeister; Maria A Rodriguez; Lei Feng; Ana Ayala; Terry L Smith; Fernando Cabanillas; Peter McLaughlin
Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen.
Cancer 2005;104(2):345-53.
2005: Peter McLaughlin; Elihu Estey; Armand B. Glassman; Jorge Romaguera; Felipe Samaniego; Ana Ayala; Kimberly Hayes; Anne Marie Maddox; H Alejandro Preti; Fredrick B Hagemeister
Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha.
Blood 2005;105(12):4573-5.
2005: Paolo Anderlini; Rima M Saliba; Sandra Acholonu; Grace-Julia Okoroji; Michele Donato; Sergio Giralt; Borje Andersson; Naoto T Ueno; Issa Khouri; Marcos De Lima; Chitra Hosing; Agueda Cohen; Cindy Ippoliti; Jorge Romaguera; M A Rodriguez; Barbara Pro; Luis Fayad; Andre Goy; Anas Younes; Richard E Champlin
Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen.
Bone marrow transplantation 2005;35(10):943-51.
2005: Nancy P Caraway; Jun Gu; Pei Lin; Jorge Romaguera; Armand B. Glassman; Ruth Katz
The utility of interphase fluorescence in situ hybridization for the detection of the translocation t(11;14)(q13;q32) in the diagnosis of mantle cell lymphoma on fine-needle aspiration specimens.
Cancer 2005;105(2):110-8.
2005: Andre Goy; Anas Younes; Peter McLaughlin; Barbara Pro; Jorge Romaguera; Fredrick Hagemeister; Luis Fayad; Nam H Dang; Felipe Samaniego; Michael Wang; Kristine Broglio; Barry Samuels; Frederic Gilles; Andreas H Sarris; Susan Hart; Elizabeth Trehu; David P Schenkein; Fernando Cabanillas; Alma M Rodriguez
Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(4):667-75.
2005: Jorge Romaguera; Fredrick B Hagemeister
Lymphoma of the colon.
Current opinion in gastroenterology 2005;21(1):80-4.
2004: Nam H Dang; Fredrick B Hagemeister; Barbara Pro; Peter McLaughlin; Jorge Romaguera; Dan Jones; Barry Samuels; Felipe Samaniego; Anas Younes; Michael Wang; Andre Goy; Maria A Rodriguez; Pamela L Walker; Yolanda Arredondo; Ann T Tong; Luis Fayad
Phase II study of denileukin diftitox for relapsed/refractory B-Cell non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(20):4095-102.
2004: Anas Younes; Barbara Pro; Michael J Robertson; Ian W Flinn; Jorge Romaguera; Fredrick Hagemeister; Nam H Dang; Paolo Fiumara; Evelyne M Loyer; Fernando Cabanillas; Peter W McLaughlin; Maria A Rodriguez; Felipe Samaniego
Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin's lymphoma and Hodgkin's disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(16):5432-8.
2004: Uday Popat; Chitra Hosing; Rima M Saliba; Paolo Anderlini; Koen van Besien; Donna Przepiorka; Issa F Khouri; James L Gajewski; David F Claxton; Sergio Giralt; M Rodriguez; Jorge Romaguera; Fredrick Hagemeister; Chul Ha; J Cox; Fernando Cabanillas; Borje S Andersson; Richard E Champlin
Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma.
Bone marrow transplantation 2004;33(10):1015-23.
2004: Jun Gu; Yang O Huh; Feng Jiang; Nancy P Caraway; Jorge Romaguera; Tanweer Zaidi; Ricardo L Fernandez; Huazhong Zhang; Issa F Khouri; Ruth Katz
Evaluation of peripheral blood involvement of mantle cell lymphoma by fluorescence in situ hybridization in comparison with immunophenotypic and morphologic findings.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004;17(5):553-60.
2004: Barbara Pro; Anas Younes; Maher Albitar; Nam H Dang; Felipe Samaniego; Jorge Romaguera; Peter McLaughlin; Fredrick B Hagemeister; Maria A Rodriguez; Marilyn Clemons; Fernando Cabanillas
Thalidomide for patients with recurrent lymphoma.
Cancer 2004;100(6):1186-9.
2004: Apostolia-Maria Tsimberidou; Francis Giles; Jorge Romaguera; Madeleine Duvic; Razelle Kurzrock
Activity of interferon-alpha and isotretinoin in patients with advanced, refractory lymphoid malignancies.
Cancer 2004;100(3):574-80.
2003: Nam H Dang; Fredrick B Hagemeister; Madeleine Duvic; Jorge Romaguera; Anas Younes; Dan Jones; Barry Samuels; Luis Fayad; Barbara Pro; Felipe Samaniego; Andreas H Sarris; Andre Goy; Peter McLaughlin; Ann T Tong; Pamela L Walker; Lili Paz Tiongson; Terry L Smith; Yang O Huh; Chikao Morimoto; Maria A Rodriguez
Pentostatin in T-non-Hodgkin's lymphomas: efficacy and effect on CD26+ T lymphocytes.
Oncology reports 2003;10(5):1513-8.
2003: Anas Younes; Jorge Romaguera; Fredrick Hagemeister; Peter McLaughlin; Maria A Rodriguez; Paolo Fiumara; Andre Goy; Sima Jeha; John T Manning; Dan Jones; Lynne V Abruzzo; L Jeffrey Medeiros
A pilot study of rituximab in patients with recurrent, classic Hodgkin disease.
Cancer 2003;98(2):310-4.
2003: John F Seymour; Barbara Pro; Lillian M Fuller; John T Manning; Fredrick B Hagemeister; Jorge Romaguera; Maria A Rodriguez; Chul Ha; Terry L Smith; Ana Ayala; Mark Hess; James D Cox; Fernando Cabanillas; Peter McLaughlin
Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(11):2115-22.
2003: Jorge Romaguera; L Jeffrey Medeiros; Fredrick B Hagemeister; Luis Fayad; Maria A Rodriguez; Barbara Pro; Anas Younes; Peter McLaughlin; Andre Goy; Andreas H Sarris; Nam H Dang; Felipe Samaniego; H M Brown; Harish K Gagneja; Fernando Cabanillas
Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma.
Cancer 2003;97(3):586-91.
2002: Apostolia-Maria Tsimberidou; Peter McLaughlin; Anas Younes; Maria A Rodriguez; Fredrick B Hagemeister; Andreas H Sarris; Jorge Romaguera; Mark Hess; Terry L Smith; Ying Yang; Ana Ayala; Alejandro Preti; Ming-Sheng Lee; Fernando Cabanillas
Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma.
Blood 2002;100(13):4351-7.
2002: Hoon K Lee; Richard B Wilder; Dan Jones; Chul Ha; Barbara Pro; Maria A Rodriguez; Jorge Romaguera; Fernando Cabanillas; Jose Rodriguez; James D Cox
Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomas.
Leukemia & lymphoma 2002;43(9):1769-75.
2002: Bita Esmaeli; James L Murray; M Amir Ahmadi; Aresu Naderi; Sanjay Singh; Jorge Romaguera; Christine White; Peter McLaughlin
Immunotherapy for low-grade non-hodgkin secondary lymphoma of the orbit.
Archives of ophthalmology 2002;120(9):1225-7.
2002: Andreas H Sarris; Alexandria Phan; Andre Goy; Jorge Romaguera; Fredrick B Hagemeister; Maria A Rodriguez; Peter McLaughlin; Barbara Pro; L Jeffrey Medeiros; Barry Samuels; Ofelia M Mesina; Archie Bleyer; Fernando Cabanillas
Irinotecan in relapsed or refractory non-Hodgkin's lymphomas. Indications of activity in a phase II trial.
Oncology (Williston Park, N.Y.) 2002;16(8 Suppl 7):27-31.
2002: Carlo Visco; L Jeffrey Medeiros; Dan Jones; T Smith; Maria A Rodriguez; Peter McLaughlin; Jorge Romaguera; Fernando Cabanillas; Andreas H Sarris
Primary cutaneous non-Hodgkin's lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(8):1290-9.
2002: Richard B Wilder; Maria A Rodriguez; L Jeffrey Medeiros; Susan L Tucker; Chul Ha; Jorge Romaguera; Barbara Pro; Mark A Hess; Fernando Cabanillas; James D Cox
International prognostic index-based outcomes for diffuse large B-cell lymphomas.
Cancer 2002;94(12):3083-8.
2002: Andreas H Sarris; Alexandria Phan; Madeleine Duvic; Jorge Romaguera; Peter McLaughlin; Ofelia M Mesina; K King; L Jeffrey Medeiros; George Z Rassidakis; Barry Samuels; Fernando Cabanillas
Trimetrexate in relapsed T-cell lymphoma with skin involvement.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(12):2876-80.
2002: L Jeffrey Medeiros; Seema Hai; Vilmos A Thomazy; Oscar C Estalilla; Jorge Romaguera; Rajyalakshmi Luthra
Real-time RT-PCR assay for quantifying cyclin D1 mRNA in B-cell non-Hodgkin's lymphomas.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2002;15(5):556-64.
2002: George Z Rassidakis; L Jeffrey Medeiros; Simonetta Viviani; Valeria Bonfante; Gianpaolo Nadali; Theodoros P Vassilakopoulos; Ofelia M Mesina; Marco Herling; Maria K Angelopoulou; Roberto Giardini; Marco Chilosi; Christos Kittas; Peter McLaughlin; Maria A Rodriguez; Jorge Romaguera; Gianni Bonadonna; ALESSANDRO MASSIMO GIANNI; Giovanni Pizzolo; Gerassimos A Pangalis; Fernando Cabanillas; Andreas H Sarris
CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1278-87.
2002: Ibrahim Barista; Fernando Cabanillas; Jorge Romaguera; Issa F Khouri; Y Yang; Terry L Smith; S S Strom; L Jeffrey Medeiros; Fredrick B Hagemeister
Is there an increased rate of additional malignancies in patients with mantle cell lymphoma?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(2):318-22.
2002: Richard B Wilder; Jorge Romaguera; Susan L Tucker; Chul Ha; Mark A Hess; Fernando Cabanillas; James D Cox
Results with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone followed by radiotherapy with or without prechemotherapy surgical debulking for patients with bulky, aggressive lymphoma.
Cancer 2002;94(3):601-5.
2001: R D Page; Jorge Romaguera; B Osborne; L Jeffrey Medeiros; J Rodriguez; LB North; C Sanz-Rodriguez; Fernando Cabanillas
Primary hepatic lymphoma: favorable outcome after combination chemotherapy.
Cancer 2001;92(8):2023-9.
2001: J Rodriguez; Mark F Munsell; Salim Yazji; Fredrick B Hagemeister; Anas Younes; Borje Andersson; Sergio Giralt; James L Gajewski; Marcos De Lima; Daniel Couriel; Jorge Romaguera; Fernando Cabanillas; Richard E Champlin; Issa F Khouri
Impact of high-dose chemotherapy on peripheral T-cell lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(17):3766-70.
2001: Anas Younes; H Alejandro Preti; Fredrick B Hagemeister; Peter McLaughlin; Jorge Romaguera; Maria A Rodriguez; Barry Samuels; J Lynn Palmer; Fernando Cabanillas
Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(7):923-7.
2001: Andreas H Sarris; Jorge Romaguera; Fredrick B Hagemeister; Maria A Rodriguez; Peter McLaughlin; Barbara Pro; Anas Younes; Ofelia M Mesina; Fernando Cabanillas; L Jeffrey Medeiros; Barry Samuels
Irinotecan in relapsed or refractory non-Hodgkin's lymphoma.
Oncology (Williston Park, N.Y.) 2001;15(7 Suppl 8):53-6.
2001: Carlo Visco; L Jeffrey Medeiros; Ofelia M Mesina; Maria A Rodriguez; Fredrick B Hagemeister; Peter McLaughlin; Jorge Romaguera; Fernando Cabanillas; Andreas H Sarris
Non-Hodgkin's lymphoma affecting the testis: is it curable with doxorubicin-based therapy?
Clinical lymphoma 2001;2(1):40-6.
2001: Apostolia-Maria Tsimberidou; Andreas H Sarris; L Jeffrey Medeiros; Ofelia M Mesina; Maria A Rodriguez; Fredrick B Hagemeister; Jorge Romaguera; Barbara Pro; Peter McLaughlin; N Dang; Fernando Cabanillas
Hodgkin's disease in patients infected with human immunodeficiency virus: frequency, presentation and clinical outcome.
Leukemia & lymphoma 2001;41(5-6):535-44.
2001: Bita Esmaeli; C Koller; N Papadopoulos; Jorge Romaguera
Interferon-induced retinopathy in asymptomatic cancer patients.
Ophthalmology 2001;108(5):858-60.
2001: Jose Rodriguez; Jorge Romaguera; Ruth Katz; J Said; Fernando Cabanillas
Primary effusion lymphoma in an HIV-negative patient with no serologic evidence of Kaposi's sarcoma virus.
Leukemia & lymphoma 2001;41(1-2):185-9.
2001: Andreas H Sarris; Ira Braunschweig; L Jeffrey Medeiros; Madeleine Duvic; Chul Ha; Maria A Rodriguez; Fredrick B Hagemeister; Peter McLaughlin; Jorge Romaguera; J Cox; Fernando Cabanillas
Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):398-405.
2000: Peter McLaughlin; Fredrick B Hagemeister; Maria A Rodriguez; Andreas H Sarris; O Pate; Anas Younes; Ming-Sheng Lee; Nam H Dang; Jorge Romaguera; Alejandro Preti; N McAda; Fernando Cabanillas
Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma.
Seminars in oncology 2000;27(6 Suppl 12):37-41.
2000: Jose Rodriguez; Peter McLaughlin; Luis Fayad; M Santiago; Mark Hess; Maria A Rodriguez; Jorge Romaguera; Fredrick Hagemeister; Andrew Lamb; Fernando Cabanillas
Follicular large cell lymphoma: long-term follow-up of 62 patients treated between 1973-1981.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(12):1551-6.
2000: Andreas H Sarris; A Psyrri; Fredrick Hagemeister; Jorge Romaguera; Peter McLaughlin; Maria A Rodriguez; CR Bachier; Anas Younes; Ofelia M Mesina; M Oholendt; L Jeffrey Medeiros; Barry Samuels; Laurel M Adams; Fernando Cabanillas
Infusional vinorelbine in relapsed or refractory lymphomas.
Leukemia & lymphoma 2000;39(3-4):291-9.
2000: Paolo Anderlini; Sergio Giralt; Borje Andersson; Naoto T Ueno; Issa Khouri; Sandra Acholonu; Agueda Cohen; Martin Körbling; J Manning; Jorge Romaguera; Andreas H Sarris; Fredrick Hagemeister; Peter McLaughlin; Fernando Cabanillas; Richard E Champlin
Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's disease.
Bone marrow transplantation 2000;26(6):615-20.
2000: Jose Rodriguez; Jorge Romaguera; J Manning; Nelson G Ordonez; Chul Ha; Farhad Ravandi; Fernando Cabanillas
Nasal-type T/NK lymphomas: a clinicopathologic study of 13 cases.
Leukemia & lymphoma 2000;39(1-2):139-44.
2000: Jorge Romaguera; Issa F Khouri; Hagop M Kantarjian; Fredrick B Hagemeister; Maria A Rodriguez; Peter McLaughlin; Andreas H Sarris; Anas Younes; Jose Rodriguez; Fernando Cabanillas
Untreated aggressive mantle cell lymphoma: results with intensive chemotherapy without stem cell transplant in elderly patients.
Leukemia & lymphoma 2000;39(1-2):77-85.
2000: Ruth Katz; Nancy P Caraway; Jun Gu; Feng Jiang; L A Pasco-Miller; Armand B. Glassman; Rajyalakshmi Luthra; Kimberly J Hayes; Jorge Romaguera; Fernando Cabanillas; L Jeffrey Medeiros
Detection of chromosome 11q13 breakpoints by interphase fluorescence in situ hybridization. A useful ancillary method for the diagnosis of mantle cell lymphoma.
American journal of clinical pathology 2000;114(2):248-57.
2000: Linh N Nguyen; Chul Ha; Mark Hess; Jorge Romaguera; JT Manning; Fernando Cabanillas; James D Cox
The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinum.
International journal of radiation oncology, biology, physics 2000;47(5):1281-5.
2000: A López-Guillermo; Fernando Cabanillas; Peter McLaughlin; T Smith; Fredrick Hagemeister; MA Rodríguez; Jorge Romaguera; Anas Younes; Andreas H Sarris; H Alejandro Preti; WC Pugh; Ming-Sheng Lee
Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC series.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11 Suppl 1():137-40.
2000: Andreas H Sarris; Fredrick Hagemeister; Jorge Romaguera; Maria A Rodriguez; Peter McLaughlin; Apostolia-Maria Tsimberidou; L Jeffrey Medeiros; Barry Samuels; O Pate; M Oholendt; Andrew Lamb; C Burge; Fernando Cabanillas
Liposomal vincristine in relapsed non-Hodgkin's lymphomas: early results of an ongoing phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(1):69-72.
1999: Chung-Wu Lin; Susan O'Brien; J Faber; Taghi Manshouri; Jorge Romaguera; Yang O Huh; Andrew Lamb; Michael Keating; Maher Albitar
De novo CD5+ Burkitt lymphoma/leukemia.
American journal of clinical pathology 1999;112(6):828-35.
1999: Issa F Khouri; Ming-Sheng Lee; Jorge Romaguera; N Mirza; Andrew Lamb; Martin Korbling; Maher Albitar; Sergio Giralt; Barry Samuels; Paolo Anderlini; Jose Rodriguez; B von Wolff; James L Gajewski; Fernando Cabanillas; Richard Champlin
Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(11):1293-9.
1999: Michele L Donato; Richard E Champlin; Koen van Besien; Martin Korbling; Fernando Cabanillas; Paolo Anderlini; J G Gajewski; Jo Lauppe; April Durett; Borje Andersson; Sergio Giralt; Issa Khouri; Fredrick Hagemeister; Jorge Romaguera; Andreas H Sarris; Peter McLaughlin; Anas Younes; Cindy Ippoliti; D A Blamble; Jeane Hester; Adrian Gee; Maria A Rodriguez
Intensive dose ifosfamide and etoposide with G-CSF for stem cell mobilization in patients with non-Hodgkin's lymphoma.
Leukemia & lymphoma 1999;35(3-4):317-24.
1999: Rajyalakshmi Luthra; Andreas H Sarris; Seema Hai; A V Paladugu; Jorge Romaguera; Fernando Cabanillas; L Jeffrey Medeiros
Real-time 5'-->3' exonuclease-based PCR assay for detection of the t(11;14)(q13;q32).
American journal of clinical pathology 1999;112(4):524-30.
1999: G Steinbach; R Ford; GA Glober; Dory A Sample; Fredrick B Hagemeister; Patrick M Lynch; P W McLaughlin; M A Rodriguez; Jorge Romaguera; Andreas H Sarris; Anas Younes; R Luthra; JT Manning; C M Johnson; Sandeep Lahoti; Y Shen; J E Lee; RJ Winn; Robert Genta; D Y Graham; Fernando Cabanillas
Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial.
Annals of internal medicine 1999;131(2):88-95.
1999: Jose Rodriguez; Maria A Rodriguez; Luis Fayad; Peter McLaughlin; F Swan; Andreas H Sarris; Jorge Romaguera; Borje Andersson; Fernando Cabanillas; Fredrick B Hagemeister
ASHAP: a regimen for cytoreduction of refractory or recurrent Hodgkin's disease.
Blood 1999;93(11):3632-6.
1999: A López-Guillermo; Fernando Cabanillas; Timothy J McDonnell; Peter McLaughlin; T Smith; WC Pugh; Fredrick Hagemeister; MA Rodríguez; Jorge Romaguera; Anas Younes; Andreas H Sarris; H Alejandro Preti; Ming-Sheng Lee
Correlation of bcl-2 rearrangement with clinical characteristics and outcome in indolent follicular lymphoma.
Blood 1999;93(9):3081-7.
1999: Andreas H Sarris; Kay-Oliver Kliche; P Pethambaram; Alejandro Preti; S Tucker; CM Jackow; O Messina; WC Pugh; Fredrick B Hagemeister; Peter McLaughlin; Maria A Rodriguez; Jorge Romaguera; Herbert A Fritsche; T Witzig; Madeleine Duvic; Michael Andreeff; Fernando Cabanillas
Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(4):433-40.
1999: Jose Rodriguez; Peter McLaughlin; Fredrick B Hagemeister; Luis Fayad; Maria A Rodriguez; M Santiago; Mark Hess; Jorge Romaguera; Fernando Cabanillas
Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic features.
Blood 1999;93(7):2202-7.
1999: Jorge Romaguera; Maria A Rodriguez; Fredrick B Hagemeister; Peter McLaughlin; J Rodriguez; A Preti; Anas Younes; Andreas H Sarris; Fernando Cabanillas
Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/mesna for patients with relapsed or refractory non-Hodgkin's lymphoma after failure to cytarabine/cisplatin combination.
Investigational new drugs 1999;17(2):187-92.
1998: Jorge Romaguera; Fredrick B Hagemeister; Peter McLaughlin; Maria A Rodriguez; CR Bachier; H Alejandro Preti; Andreas H Sarris; Donna Weber; Anas Younes; Fernando Cabanillas
Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesna and consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphoma.
Leukemia & lymphoma 1998;32(1-2):97-106.
1998: Anas Younes; Jorge Romaguera; Ofelia M Mesina; Fredrick Hagemeister; Andreas H Sarris; Maria A Rodriguez; Peter McLaughlin; H Alejandro Preti; CR Bachier; Fernando Cabanillas
Paclitaxel plus high-dose cyclophosphamide with G-CSF support in patients with relapsed and refractory aggressive non-Hodgkin's lymphoma.
British journal of haematology 1998;103(3):678-83.
1998: Issa F Khouri; Jorge Romaguera; Andrew Lamb; J Lynn Palmer; WC Pugh; Martin Korbling; Fredrick Hagemeister; Barry Samuels; A Rodriguez; Sergio Giralt; Anas Younes; Donna Przepiorka; David F Claxton; Fernando Cabanillas; Richard Champlin
Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(12):3803-9.
1998: Fernando Cabanillas; J Rodriguez-Diaz Pavón; Fredrick B Hagemeister; Peter McLaughlin; Maria A Rodriguez; Jorge Romaguera; K Dong; T Moon
Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(5):511-8.
1998: A López-Guillermo; Fernando Cabanillas; Peter McLaughlin; T Smith; Fredrick Hagemeister; MA Rodríguez; Jorge Romaguera; Anas Younes; Andreas H Sarris; H Alejandro Preti; WC Pugh; Ming-Sheng Lee
The clinical significance of molecular response in indolent follicular lymphomas.
Blood 1998;91(8):2955-60.
1998: Koen van Besien; Chul Ha; S Murphy; Peter McLaughlin; A Rodriguez; K Amin; A Forman; Jorge Romaguera; Fredrick Hagemeister; Anas Younes; CR Bachier; Andreas H Sarris; K S Sobocinski; James D Cox; Fernando Cabanillas
Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma.
Blood 1998;91(4):1178-84.
1998: Jorge Romaguera; J Rodríguez Díaz-Pavon; L Carías; Fredrick B Hagemeister; Peter McLaughlin; M A Rodríguez; Andreas H Sarris; Anas Younes; Alejandro Preti; CR Bachier; E Llerena; Fernando Cabanillas
Use of the international prognostic index and the tumor score to detect poor-risk patients with primary mediastinal large B-cell lymphoma: a study of 37 previously untreated patients.
Leukemia & lymphoma 1998;28(3-4):295-306.
1998: Uday Popat; D Przepiork; Richard Champlin; WC Pugh; K Amin; RC Mehra; J Rodriguez; Sergio Giralt; Jorge Romaguera; A Rodriguez; Alejandro Preti; Borje Andersson; Issa Khouri; David F Claxton; Marcos De Lima; Michele Donato; Paolo Anderlini; James L Gajewski; Fernando Cabanillas; Koen van Besien
High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):63-9.
1997: Marvin L Meistrich; Gene Wilson; K Mathur; Lillian M Fuller; Maria A Rodriguez; Peter McLaughlin; Jorge Romaguera; Fernando Cabanillas; Chul Ha; Larry I Lipshultz; Fredrick B Hagemeister
Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(12):3488-95.
1997: Anas Younes; Maria A Rodriguez; Peter McLaughlin; LB North; Andreas H Sarris; O Pate; Fredrick B Hagemeister; Jorge Romaguera; Alejandro Preti; CR Bachier; Fernando Cabanillas
Phase I study of fludarabine and paclitaxel for the treatment of low-grade non-Hodgkin's lymphoma.
Leukemia & lymphoma 1997;26(1-2):77-82.
1997: Anas Younes; JP Ayoub; Andreas H Sarris; Fredrick Hagemeister; LB North; O Pate; Peter McLaughlin; Maria A Rodriguez; Jorge Romaguera; R Kurzrock; Alejandro Preti; CR Bachier; T Smith; Fernando Cabanillas
Paclitaxel activity for the treatment of non-Hodgkin's lymphoma: final report of a phase II trial.
British journal of haematology 1997;96(2):328-32.
1997: Anas Younes; JP Ayoub; Andreas H Sarris; LB North; O Pate; Peter McLaughlin; Maria A Rodriguez; Jorge Romaguera; Fredrick Hagemeister; CR Bachier; Alejandro Preti; Fernando Cabanillas
Paclitaxel (Taxol) for the treatment of lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 1():129-31.
1996: Jorge Romaguera; S Meilus; Jose Rodriguez; T Brooks; Nelson G Ordonez; Fernando Cabanillas
Endocrine characterization of primary mediastinal lymphoma.
Leukemia & lymphoma 1996;23(5-6):613-5.
1996: Peter McLaughlin; F B Hagemeister; Jorge Romaguera; Andreas H Sarris; O Pate; Anas Younes; F Swan; Michael Keating; Fernando Cabanillas
Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(4):1262-8.
1996: J F Seymour; Peter McLaughlin; Lillian M Fuller; F B Hagemeister; M Hess; F Swan; Jorge Romaguera; Maria A Rodriguez; PC Besa; J Cox; Fernando Cabanillas
High rate of prolonged remissions following combined modality therapy for patients with localized low-grade lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(2):157-63.
1996: Anas Younes; JP Ayoub; F B Hagemeister; Peter McLaughlin; Andreas H Sarris; Maria A Rodriguez; F Swan; Jorge Romaguera; J Martin; Fernando Cabanillas
No effect of 96-hour paclitaxel infusion in patients with relapsed non-Hodgkin's lymphoma refractory to a 3-hour infusion schedule.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):543-8.
1996: Andreas H Sarris; Anas Younes; Peter McLaughlin; D Moore; F Hagemeister; F Swan; Maria A Rodriguez; Jorge Romaguera; LB North; P Mansfield; D Callendar; O Mesina; Fernando Cabanillas
Cyclosporin A does not reverse clinical resistance to paclitaxel in patients with relapsed non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):233-9.
1995: Jorge Romaguera; J Garcia-Foncillas; Fernando Cabanillas
16-year experience at M. D. Anderson Cancer Center with primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large cell lymphoma.
Leukemia & lymphoma 1995;20(1-2):97-102.
1995: Maria A Rodriguez; F C Cabanillas; F B Hagemeister; Peter McLaughlin; Jorge Romaguera; F Swan; W Velasquez
A phase II trial of mesna/ifosfamide, mitoxantrone and etoposide for refractory lymphomas.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(6):609-11.
1995: W F Symmans; Ruth Katz; N G Ordoñez; H Dalton; Jorge Romaguera; Fernando Cabanillas
Transformation of follicular lymphoma. Expression of p53 and bcl-2 oncoprotein, apoptosis and cell proliferation.
Acta cytologica 1995;39(4):673-82.
1995: Maria A Rodriguez; F C Cabanillas; W Velasquez; F B Hagemeister; Peter McLaughlin; F Swan; Jorge Romaguera
Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(7):1734-41.
1995: S Suki; F Swan; S Tucker; Herbert A Fritsche; J R Redman; Maria A Rodriguez; Peter McLaughlin; Jorge Romaguera; F B Hagemeister; W S Velasquez
Risk classification for large cell lymphoma using lactate dehydrogenase, beta-2 microglobulin, and thymidine kinase.
Leukemia & lymphoma 1995;18(1-2):87-92.
1995: Anas Younes; Andreas H Sarris; A Melnyk; Jorge Romaguera; Peter McLaughlin; F Swan; Maria A Rodriguez; F Hagemeister; D Moore; LB North
Three-hour paclitaxel infusion in patients with refractory and relapsed non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(3):583-7.
1995: D F Moore; F Swan; J Yau; Maria A Rodriguez; Peter McLaughlin; Andreas H Sarris; Jorge Romaguera; Anas Younes; F B Hagemeister; Fernando Cabanillas
Cyclosporin plus doxorubicin, vincristine and etoposide in the treatment of refractory non-Hodgkin's lymphoma: a phase II study.
Clinical oncology (Royal College of Radiologists (Great Britain)) 1995;7(5):300-3.
1994: Jose Rodriguez; WC Pugh; Jorge Romaguera; Rajyalakshmi Luthra; F B Hagemeister; Peter McLaughlin; Maria A Rodriguez; F Swan; Fernando Cabanillas
Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoral mass and low beta 2 microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenase.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(9):847-9.
1994: Jose Rodriguez; WC Pugh; Jorge Romaguera; Fernando Cabanillas
Primary mediastinal large cell lymphoma.
Hematological oncology 1994;12(4):175-84.
1994: W S Velasquez; Peter McLaughlin; S Tucker; F B Hagemeister; F Swan; Maria A Rodriguez; Jorge Romaguera; Edward B Rubenstein; Fernando Cabanillas
ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(6):1169-76.
1994: Jorge Romaguera; J T Manning; C S Tornos; Jose Rodriguez; T E Brooks; WC Pugh; Nelson G Ordonez; AM Goodacre; Fernando Cabanillas
Long-term prognostic importance of primary Ki-1 (CD30) antigen expression and anaplastic morphology in adult patients with diffuse large-cell lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(4):317-22.
1994: F B Hagemeister; R Purugganan; L Fuller; Peter McLaughlin; F Swan; Jorge Romaguera; M Rodriguez; Fernando Cabanillas
Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
Seminars in hematology 1994;31(2 Suppl 3):36-43.
1994: Peter McLaughlin; F B Hagemeister; F Swan; Fernando Cabanillas; O Pate; Jorge Romaguera; Maria A Rodriguez; J R Redman; Michael Keating
Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(3):575-9.
1994: F B Hagemeister; R Purugganan; D A Podoloff; M Hess; Maria A Rodriguez; Peter McLaughlin; F Swan; Jorge Romaguera; Fernando Cabanillas
The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():59-63.
1994: F B Hagemeister; R Khetan; P Allen; Peter McLaughlin; Maria A Rodriguez; F Swan; Jorge Romaguera; Fernando Cabanillas
Stage, serum LDH, and performance status predict disease progression and survival in HIV-associated lymphomas.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():41-6.
1994: Jorge Romaguera; Maria A Rodriguez; F B Hagemeister; Peter McLaughlin; F Swan; D F Moore; Andreas H Sarris; Anas Younes; D Hill; Fernando Cabanillas
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas.
Investigational new drugs 1994;12(3):217-22.
1994: Peter McLaughlin; F B Hagemeister; F Swan; Fernando Cabanillas; Jorge Romaguera; Maria A Rodriguez; M S Lee; O Pate; Andreas H Sarris; Anas Younes
Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: high remission rates and reversion to negative of peripheral blood bcl-2 rearrangement.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():73-7.
1993: Peter McLaughlin; Fernando Cabanillas; F B Hagemeister; F Swan; Jorge Romaguera; S Taylor; Maria A Rodriguez; W S Velasquez; J R Redman; Jordan U Gutterman
CHOP-Bleo plus interferon for stage IV low-grade lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(3):205-11.
1993: Jorge Romaguera
Can we identify patients with low grade lymphoma for frontline ABMT?
Leukemia & lymphoma 1993;10 Suppl():9-15.
1993: Jorge Romaguera; WC Pugh; Rajyalakshmi Luthra; AM Goodacre; Fernando Cabanillas
The clinical relevance of t(14;18)/BCL-2 rearrangement and DEL 6q in diffuse large cell lymphoma and immunoblastic lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(1):51-4.
1993: Jose Rodriguez; WC Pugh; Jorge Romaguera; Fernando Cabanillas
Anaplastic Ki-1 + large-cell lymphoma.
Cancer investigation 1993;11(5):554-8.
1992: J Rodríguez; F Cabanillas; P McLaughlin; F Swan; M Rodríguez; F Hagemeister; Jorge Romaguera
A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the 'tumor score'.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(9):711-7.
1992: F B Hagemeister; L Fuller; Peter McLaughlin; M Rodriguez; Jorge Romaguera; F Swan; Fernando Cabanillas
NOVP and radiotherapy for early-staged Hodgkin's disease: an interim analysis.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 4():87-90.
1991: Jorge Romaguera; Peter McLaughlin; LB North; D Dixon; K B Silvermintz; L A Garnsey; W S Velasquez; F B Hagemeister; Fernando Cabanillas
Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(5):762-9.
1990: F B Hagemeister; Fernando Cabanillas; W S Velásquez; Marvin L Meistrich; Jan C Liang; Peter McLaughlin; J R Redman; Jorge Romaguera; M A Rodríguez; F Swan
NOVP: a novel chemotherapeutic regimen with minimal toxicity for treatment of Hodgkin's disease.
Seminars in oncology 1990;17(6 Suppl 10):34-8; discussion 38-40.